换一批Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.
第一作者：
Naomi,Wilcox
第一单位：
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
作者：
Naomi,Wilcox [1]
;
Martine,Dumont [2]
;
Anna,González-Neira [3]
;
Sara,Carvalho [1]
;
Charles,Joly Beauparlant [2]
;
Marco,Crotti [1]
;
Craig,Luccarini [4]
;
Penny,Soucy [2]
;
Stéphane,Dubois [2]
;
Rocio,Nuñez-Torres [3]
;
Guillermo,Pita [3]
;
Eugene J,Gardner [5]
;
Joe,Dennis [1]
;
M Rosario,Alonso [3]
;
Nuria,Álvarez [3]
;
Caroline,Baynes [4]
;
Annie Claude,Collin-Deschesnes [2]
;
Sylvie,Desjardins [2]
;
Heiko,Becher [6]
;
Sabine,Behrens [7]
;
Manjeet K,Bolla [1]
;
Jose E,Castelao [8]
;
Jenny,Chang-Claude [9]
;
Sten,Cornelissen [10]
;
Thilo,Dörk [11]
;
Christoph,Engel [12]
;
Manuela,Gago-Dominguez [13]
;
Pascal,Guénel [14]
;
Andreas,Hadjisavvas [15]
;
Eric,Hahnen [16]
;
Mikael,Hartman [17]
;
Belén,Herráez [3]
;
SGBCC Investigators [7]
;
Audrey,Jung [10]
;
Renske,Keeman [18]
;
Marion,Kiechle [19]
;
Jingmei,Li [15]
;
Maria A,Loizidou [1]
;
Michael,Lush [20]
;
Kyriaki,Michailidou [15]
;
Mihalis I,Panayiotidis [21]
;
Xueling,Sim [22]
;
Soo Hwang,Teo [4]
;
Jonathan P,Tyrer [23]
;
Lizet E,van der Kolk [24]
;
Cecilia,Wahlström [1]
;
Qin,Wang [25]
;
John R B,Perry [26]
;
Javier,Benitez [27]
;
Marjanka K,Schmidt [28]
;
Rita K,Schmutzler [29]
;
Paul D P,Pharoah [30]
;
Arnaud,Droit [4]
;
Alison M,Dunning [24]
;
Anders,Kvist [31]
;
Peter,Devilee [32]
;
Douglas F,Easton [2]
;
Jacques,Simard
作者单位：
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
[1]
Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
[2]
Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
[3]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
[4]
MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
[5]
Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[6]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[7]
Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
[8]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.;Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
[9]
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
[10]
Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
[11]
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.;LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
[12]
Cancer Genetics and Epidemiology Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
[13]
Team 'Exposome and Heredity,' CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France.
[14]
Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
[15]
Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
[16]
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.;Department of Surgery, National University Health System, Singapore City, Singapore.;Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
[17]
Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
[18]
Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore City, Singapore. lijm1@gis.a-star.edu.sg.
[19]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.;Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
[20]
Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.
[21]
Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Malaysia.;Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia.
[22]
Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.
[23]
Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
[24]
MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.;Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
[25]
Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.;Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
[26]
Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.;Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.
[27]
Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.;Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
[28]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
[29]
Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.;Département de Médecine Moléculaire, Faculté de Médecine, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
[30]
Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.;Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
[31]
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.;Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
[32]
DOI
10.1038/s41588-023-01466-z
PMID
37592023
发布时间
2025-05-30
- 浏览0
Nature genetics
Nature genetics
1435-1439页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
